British Society for Rheumatology > Knowledge > Excellence > Audits


Knowledge * Excellence * Audits

National Early Inflammatory Arthritis Audit

This audit will help to improve the quality of care for people living with inflammatory arthritis across England and Wales. Commissioned by the Healthcare Quality Improvement Partnership (HQIP), as part of the National Clinical Audit Programme, the National Early Inflammatory Arthritis Audit will be carried out by BSR, with support from Kings College London and Netsolving.

Dr Jo Ledingham, Clinical Audit Director
Dr Jo Ledingham, Clinical Audit Director

"HQIP support and funding for phase 2 of this audit underlines the importance to the health economy, but also to society more widely, of the early identification and treatment of inflammatory arthritis. Many rheumatology units have struggled to achieve the quality statements set by NICE and this audit should be a tool that can be used to assist units in improving the care they can provide to these patients’"

Benefits of taking part:

  • The audit will generate unit-level data, benchmarked to regional and national comparators against NICE Quality Standard 33 and other key metrics
  • It will quantify the impact of the last audit in more detail, measuring how reconfiguration and staffing changes have changed practice and patient care
Clinician writing notes


This platform is now available.

Click here >

Female logging information via laptop


This platform is now available.

Click here >

What we are doing to support units:

  • Streamlined the amount of data the audit collects and introduced a new, more user-friendly IT system
  • Appointed 5 regional champions, based on the NHS Regions and Wales, to work with units to address emerging issues and facilitate communication with the society
  • Writing to Trust CEOs and clinical leads to raise awareness about the audit, including the requirement to participate under the terms of the standard NHS contract, and ensure appropriate resources are put into place
  • FAQs will be published within the audit tool and quarterly updates to be published post-launch. 

Data collection:

All new patients over the age of 16 years presenting for the first time with suspected inflammatory arthritis should be recruited. Data collection for patients with a diagnosis of rheumatoid arthritis will be at three time points across 12 months, assessing waiting times; time to treatment; clinical response to treatment; provision of education and patient reported outcomes. 

For patients with axial spondyloarthritis, data collected will be referral time and waiting time to first appointment.

Key dates to remember:

  • Launch of the audit - w/c 7 May
  • Publish the 1st annual reports (clinician and patient) – Autumn 2019.



Everything you need to know about the audit project, what data to collect and how - in a handy 30 minute webinar. Audit lead analyst Dr James Galloway talks you through the essentials and answers your questions. 

Register for the next live webinars to receive a recap on inclusion criteria:

Tues 2 Oct 08.30-09.00

Mon 8 October 13.00-14.00

Mon 29 Oct 17:00-17:30

Want to know more?

If you would like more information on the audit please get in touch with us.

Contact us >

Reports and case studies

Access reports from the first and second year National clinical audits, plus our collection of case studies.

View more >

Latest Tweet


New to #Twitter or want to meet fellow #tweeters? Join the official #Rheum2017 tweetup, BSR stand, 08:30, 25 Apr, exhibition hall

Contact us

British Society for Rheumatology
Bride House, 18-20 Bride Lane,
London EC4Y 8EE
T: +44 (0) 20 7842 0900
Company No: 3470316
Charity No: 1067124
VAT No: 404 5637 66

Join us

We are the UK's leading specialist medical society for rheumatology and musculoskeletal professionals, and we welcome applications from all health professionals in these fields.